Oxitan (Oxaliplatin) Injection 5mg/ml


Oxitan (Oxaliplatin) is a platinum-based drug, usually classified as alkylating group.

ATC-Code: L01XA03

Therapeutic Indications

Oxitan (Oxaliplatin) in combination with 5-fluorouracil and folinic acid is indicated for:

  • Adjuvant treatment of stage III (Duke’s C) colon carcinoma after complete resection of primary tumor
  • Treatment of metastatic colorectal carcinoma


Strength is denoted by disposable cap colour. 



Pack Size*

50 mg/10 ml 10ml clear glass vial 1
100 mg/20 ml 20ml clear glass vial 1
200 mg/40 ml 40ml clear glass bottle 1

* Not all pack sizes may be marketed or available locally.
* Product images are for illustration purposes only. 

Product Information

​Please note that this product may not be available in all countries due to different registration status. Additionally, approved indications, contraindications, side effects, warnings and all other product characteristics may differ between countries.

If you require any information, please contact your local organization.